Globally, cervical cancer is the fourth most common cancer in women, with 6,04,000 new cases in 2020. Women living with HIV are 6 times more likely to develop cervical cancer, compared to the general population, and an estimated 5% of all cervical cancer cases are attributable to HIV. The contributi

2 views • 7 slides

The flowcharts and descriptions detail the steps involved in identifying eligible patients for screening, managing patient flow during visits, and tracking screening results. The process includes reviewing patient charts, determining screening eligibility, discussing screening options with patients,

2 views • 5 slides

Screening for lung cancer is essential for early detection and intervention. CT scans have shown promise in reducing mortality rates, especially in high-risk populations. While challenges like cost and radiation risk exist, initiatives like the National Lung Screening Trial have demonstrated the eff

4 views • 28 slides

The Europe Cancer Diagnostics Market is projected to reach $12.21 billion by 2031, at a CAGR of 5.6% during the forecast period 2024\u20132031. The Europe cancer diagnostics market is driven by the rising prevalence of cancer, supporting initiatives for early cancer diagnosis, increasing investments

3 views • 4 slides

Dr. Manoj Dongare is one of the best colorectal cancer specialist in Pune which handles each and every case with utmost care. In his surgical experience, he performs many colorectal cancer surgeries successfully. His expertise in colorectal cancer surgery and surgical oncology makes him one of the b

0 views • 3 slides

The Ontario Breast Screening Program (OBSP) is a quality-assured, population-based breast cancer screening initiative administered by Cancer Care Ontario. It aims to reduce breast cancer mortality through early detection by providing biennial screenings for average-risk women aged 50-74 and annual s

3 views • 21 slides

Cancer Alliances play a crucial role in coordinating cancer care and improving outcomes for patients. The South West Lung Pathway Transformation focuses on implementing rapid assessment pathways for lung, prostate, and colorectal cancers. Their priorities include meeting waiting time standards, diag

0 views • 23 slides

Cancer nurses play a crucial role in raising awareness about effective cancer prevention methods, supporting the European Code Against Cancer, providing advice for risk reduction, promoting health literacy, and encouraging early diagnosis through screening programs. Their expertise and leadership ar

0 views • 30 slides

The Canadian Partnership Against Cancer annually collects and summarizes data on national, provincial, and territorial prostate cancer screening guidelines and strategies. Despite the absence of organized screening programs, some provinces have policies in place, with opportunistic screening by prim

0 views • 13 slides

Introduction and evaluation of Faecal Immunochemical Test (FIT) and Faecal Calprotectin for colorectal cancer screening, focusing on the indications for use, exclusion criteria, economic evaluation, and comparison with standard care. Information includes age-specific screening recommendations, diffe

0 views • 31 slides

Katie's journey with advanced colorectal cancer showcases the stark differences between a sub-optimal pathway, marked by delayed diagnosis, ineffective treatment, and inadequate palliative care, and an optimal pathway characterized by timely referrals, comprehensive support, and personalized care pl

2 views • 9 slides

Strong association of clinical biomarker - elevated DKK2 correlates with poor CRC prognosis. First-in-class therapeutic for colorectal cancer, targeting MSS CRC with multiple novel mechanisms of action and low risk for side effects. Complements current treatments like bevacizumab and shows efficacy

2 views • 11 slides

Cancer survival rates in Europe have shown variations across different types of cancer and countries. While overall cancer mortality has increased over the years, some countries have experienced declines in mortality rates. Survival rates for breast cancer between 1995-2014 ranged from 74% to 89%, w

0 views • 17 slides

This case study highlights Katie's journey through an advanced colorectal cancer care pathway, comparing a sub-optimal scenario with an ideal pathway. It emphasizes the importance of utilizing NHS RightCare methodology to enhance outcomes and value in healthcare delivery. The narrative reflects the

0 views • 14 slides

Data submission in cancer registry systems serves the purpose of contributing to a larger pool of information for monitoring cancer trends, determining patterns, guiding program planning, and assisting public health professionals. Organizations like the State Central Cancer Registries and national p

0 views • 11 slides

The FIT Pathway for suspected colorectal cancer aims to optimize referrals amidst reduced endoscopy availability due to the pandemic. By utilizing the Faecal Immunochemical Test (FIT) to triage patients, it allows for the prioritization of urgent cases, reducing the number of unnecessary colonoscopi

0 views • 34 slides

These pedigrees depict familial colorectal cancer syndromes in Ashkenazi and Iraqi Jews, showcasing early-onset MMR-proficient CRC cases linked to mutations in POLD1 and POLE genes. The pedigrees detail various cancer diagnoses, mutation carrier statuses, and ages of onset across multiple generation

0 views • 5 slides

This study explores the relevance and effectiveness of breast cancer screening for women aged 70 and above, utilizing data from the Auckland Breast Cancer Registry. It examines demographics, cancer presentation modes, characteristics, and long-term outcomes to address the question of whether screeni

0 views • 32 slides

The Humber, Coast and Vale Cancer Alliance's Cancer Champions Programme, led by Trish Rawnsley, aims to raise awareness and promote early diagnosis of cancer. Developed in North East Lincolnshire in 2011, the program has trained almost 1,000 individuals, resulting in lower emergency presentations in

0 views • 10 slides

This document outlines two projects conducted by the GI Collaborative Group focused on detecting and monitoring colorectal cancer using plasma protein markers and ctDNA/aberrantly methylated DNA markers. Project 1 aims to develop a panel of plasma biomarkers for the detection of adenomas and CRC, wh

0 views • 7 slides

Activities focusing on standardizing cancer care in Europe include quality assurance of screening programs, defining survivorship, establishing Comprehensive Cancer Control Networks, addressing socio-economic inequalities, and promoting public health genomics. The European Cancer Patient Coalition e

0 views • 7 slides

In October 2015, DB Peru launched a program in the Loreto District of Peru to provide cervical cancer screening, diagnosis, and treatment to women in the Lower Napo Valley. Partnering with local communities, the initiative aims to bridge the healthcare gap and improve living conditions. This project

0 views • 8 slides

Alcohol consumption is linked to an increased risk of various cancers, including mouth, throat, esophagus, breast, liver, and colorectal cancers. Factors such as ethanol, acetaldehyde, nutrient absorption, estrogen levels, and liver cirrhosis play a role in this risk. Even light drinking can elevate

0 views • 17 slides

The journey of cancer diagnosis brings forth various challenges, including misconceptions about nutrition. Debunking myths like soy stimulating cancer cells, sugar feeding cancer, and acidic diets curing cancer is crucial for informed decision-making. Evidence shows that soy can be a part of a healt

0 views • 11 slides

Lead by Catherine Neck, the Macmillan Cancer Rehabilitation/Recovery Package Project aims to enhance cancer care services. The Cancer Transformation Funding supports initiatives for breast, colorectal, and prostate cancers, including holistic needs assessments and wellbeing events. The SWAG Cancer A

0 views • 7 slides

The NHS Cytology Screening Programme aims to reduce incidence and mortality from cervical cancer by offering systematic, efficient screening for pre-malignant diseases. With a history dating back to 1988, the programme targets women aged 25-64, emphasizing the importance of visualizing the cervix an

1 views • 38 slides

The data presented showcases global cancer statistics from various years, highlighting the prevalence of different types of cancer across genders. It includes information on the estimated number of cancer cases, common types of cancers, and trends expected up to 2035. Lung cancer, breast cancer, and

0 views • 83 slides

Definition of screening and prevention in family practice along with the Wilson-Jungner criteria, types of screening tests, and examples like colonoscopy and breast cancer screening. Objectives include understanding screening types and targeted populations, pros and cons of screening, and appropriat

0 views • 33 slides

The study focuses on young adults under 50 diagnosed with colorectal cancer in the Somerset, Wiltshire, Avon, and Gloucestershire regions. It aims to capture data on their epidemiology, diagnostic pathways, management, and outcomes from 2009 to 2019. The background and incidence trends both globally

0 views • 24 slides

The Washington State Colorectal Cancer Task Force met on March 3, 2023, with contributors Katie Treend, Mary Miller, Kayla Kenyon, Daniel Padron, Aden Afework, Sahla Suman, and Char Raunio. The agenda included introductions, history, brainstorming, and future plans, highlighting the Task Force's jou

0 views • 12 slides

Describes the successful integration of Complementary Medicine in the network of Cancer Departments within the Tuscan Public Healthcare System. The initiative, spearheaded by experts in both Complementary Medicine and medical oncology, has led to the development of Regional Guidelines incorporating

0 views • 4 slides

Blood tests for colorectal cancer (CRC) screening can enhance compliance and options for testing. Markers like ctDNA and aberrantly methylated genes provide potential for early detection and monitoring of CRC recurrence. By combining these markers in plasma samples processed similarly, a more effect

0 views • 36 slides

Cancer survival statistics in England, analyzed in collaboration between Public Health England (PHE) and the Office for National Statistics (ONS), provide crucial insights into the effectiveness of cancer services. These statistics measure the mortality rates of cancer patients and inform various st

0 views • 25 slides

The Canadian Partnership Against Cancer conducts an annual environmental scan on cervical cancer screening guidelines and strategies across the country. Organized screening programs are available in most provinces, offering services to asymptomatic women at average risk. This scan provides insights

1 views • 46 slides

Overview of bowel preparation regimens for colorectal cancer screening, emphasizing the importance of adequate bowel cleansing to enhance the effectiveness of colonoscopy. Highlights the impact of different dosing regimens on patient compliance, colon cleansing, and detection rates of small polyps.

0 views • 20 slides

Wyoming's colorectal cancer screening programs and awareness initiatives for February and March 2023 aim to educate and encourage early detection through regular screenings. Updates on program changes and resources, including healthy recipes and the 80% screening pledge, are emphasized. Various medi

0 views • 13 slides

Learn about the spending on various types of cancer in Europe including breast cancer, colorectal cancer, prostate cancer, lung cancer, ovary cancer, and pancreatic cancer. The information is based on the Comparator Report on Cancer in Europe 2019, which covers disease burden, costs, and access to m

0 views • 7 slides

Exploring various aspects of colorectal disease and hernia, this overview covers symptoms, family history significance, approach to FHx issues, patient management based on FHx, new 2WW bowel cancer referral guidelines, and the use of faecal calprotectin as a marker. Detailed information provided by

0 views • 73 slides

Cytoplasmic expression of DCLK1-S, a novel isoform, is linked to tumor aggressiveness and poorer disease-specific survival in colorectal cancer. The study includes assessments of peptide conjugation, immunohistochemical staining in various tissues, and comparison of staining in colorectal cancer usi

0 views • 4 slides

This study details the adaptation of the Flu-FIT Program to enhance colorectal cancer screening rates within patient aligned care teams at the Veterans Affairs (VA) Department. By linking influenza immunization with colorectal cancer screening using fecal immunochemical testing, the project aimed to

0 views • 10 slides